Expanded Access Program_Tebentafusp_HMRIMelanoma_Immunocore_Patient 3_IND 159243 A Managed Access Program which will support patient access to Tebentafusp outside of clinical trials or where Tebentafusp is not yet available

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date11/1/21 → …